3172 results for «3293»
3172 results
Sirolimus-coated balloon: exploring the case- and clinical-based evidences
16 May 2024 – From EuroPCR 2024
Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...
Identification and treatment of (sub)clinical transcatheter valve thrombosis
16 May 2024 – From EuroPCR 2024
This session offers a practical guide to CT diagnosis of HALT/RLM, highlighting the importance of taking HALT/RLM seriously and providing insights into approaching HALT/HAM and the potential impact of pharmacotherapy. Gain knowledge on determining leaflet thickening and mobility through MSCT, receive updates on antithrombotic treatment strategies...
Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions
15 May 2024 – From EuroPCR 2024
Through the study of two cases, this session examines the need for stenting bifurcation lesions and the role of DEB technology in avoiding stent-related complications in long diffuse disease. It emphasizes the benefits of SELUTION SLR balloons for de novo lesions, discussing how sustained limus release...
STEMI: thrombus is the problem
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the management of STEMI patients with a high thrombotic burden. Attendees will have the opportunity to explore various strategies and techniques, such as the use of pharmacomechanical thromboaspiration, prevention of...
Align for the future with case-based discussions on next generation balloon expandable transcatheter heart valve technology
16 May 2024 – From EuroPCR 2024
Join this EuroPCR 2024 session to delve into the cutting-edge innovations and techniques shaping transcatheter heart valve interventions. Witness firsthand the versatility of the Myval Octacor THV platform, navigating through challenging scenarios with ease, explore the significance of lifetime patient management in TAVI, unveiling the novel...
PCR's Got Talent - Round 1 - Session 1
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, showcases a variety of research topics in the field of interventional cardiology. It includes presentations and discussions on sex differences in outcomes of percutaneous thrombectomy for pulmonary embolism, the validation of the MIRACLE2 score in OHCA patients, the...
CTO PCI: what a surprise!
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Clinical Case submissions, explores various challenging and unexpected scenarios encountered during CTO PCI procedures. It includes case presentations and discussions on guide wire entrapment and removal, subintimal wiring, revitalizing hope in a low ejection fraction patient, physiologic and hemodynamic considerations...
Expanding the indications of DCB for complex PCI scenarios
14 May 2024 – From EuroPCR 2024
This session, with the collaboration of various national societies, explores the use of drug-coated balloons (DCBs) in complex PCI scenarios, such as multivessel disease, left main, bifurcations, CTOs, or myocardial infarction. It includes case presentations and discussions on the procedural techniques, patient selection, and lesion preparation...
Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...
Challenging situations to access the aortic valve - Part 1
15 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that showcase challenging situations in accessing the aortic valve, including cases with severe peripheral arterial disease, tortuous aortic anatomy, and complex comorbidities. The session provides an opportunity to learn from the experiences of experts in navigating these complex scenarios...
Different treatment options for PCI in calcified lesions
15 May 2024 – From EuroPCR 2024
This session showcases various treatment options for percutaneous coronary intervention (PCI) in calcified lesions. Attendees will learn about the use of excimer laser atherectomy, intravascular lithotripsy, and other techniques to effectively manage challenging calcified coronary lesions. The session features case presentations and discussions, providing insights into...
Treatment strategies in complex coronary
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex coronary intervention cases from the EuroPCR 2024 Clinical Case submissions. The cases cover a range of challenging scenarios, including CTO with left ventricular dysfunction and VT storm, subintimal tracking and re-entry, and the decision between native vessel CTO PCI...
NSTEMI in patients in post CABG: a challenging combination
15 May 2024 – From EuroPCR 2024
This session focuses on the management of non-ST-elevation myocardial infarction (NSTEMI) in patients who have previously undergone coronary artery bypass grafting (CABG). Attendees will explore various case presentations and discussions on the challenges and treatment strategies for this complex clinical scenario, including the use of intravascular...
Endovascular treatment for acute chronic heart failure
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex endovascular cases for the treatment of acute chronic heart failure, including the use of 3D printing and virtual reality to close a pulmonary arteriovenous malformation, closure of a post-septal myectomy ventricular septal defect, and catheter-based treatment of a heart...
Clinical cases from the Call for submissions - Nurses and Allied Professionals
15 May 2024 – From EuroPCR 2024
Critical aortic stenosis: what would you choose?
14 May 2024 – From EuroPCR 2024
This session, in collaboration with the GACI (French Group of Atheroma and Interventional Cardiology), Norwegian Working Group on Interventional Cardiology, and Dutch Working Group on Interventional Cardiology, presents three challenging cases of critical aortic stenosis. The cases include a patient with bicuspid aortic stenosis, a pregnant...
Primary PCI in different situations
14 May 2024 – From EuroPCR 2024
This session, in collaboration with various international cardiology societies, focuses on the management of primary PCI in different challenging situations. It presents three cases: a late-comer STEMI patient requiring unconventional techniques, a STEMI patient with a free-floating thrombus in the left main, and a STEMI patient...
Heart team discussion for left main PCI
14 May 2024 – From EuroPCR 2024
This session focuses on the role of the heart team in the management of complex left main coronary artery disease. It presents three cases, each with a unique set of challenges, and facilitates a structured discussion with the audience to arrive at the optimal treatment strategy....
PCI: from basics to robots
14 May 2024 – From EuroPCR 2024
This session covers a wide range of topics in percutaneous coronary intervention (PCI), from fundamental aspects to the latest advancements. It includes discussions on non-fasting versus fasting before interventional procedures, radial artery puncture hemostasis, ultrasound-guided transfemoral puncture in complex PCI, the use of uninterrupted direct-acting oral...
Major Late-Breaking Trials from EuroPCR 2024
15 May 2024 – From EuroPCR 2024
This session presents the latest results from major late-breaking trials presented at EuroPCR 2024. It covers a one-month DAPT followed by 5-month ticagrelor monotherapy in acute coronary syndromes with DCB, the first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid...